Related Experiment Video
Updated: May 2, 2026

10:52
Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
7.7K
Paravalvular leak closure with two large size devices.
V K Trehan1, M S K Subhendu2, V Chaturvedi2
1Professor of Cardiology, Department of Cardiology, Gobind Ballabh Pant Hospital, New Delhi 110002, India.
Indian Heart Journal
|March 4, 2014
Summary
Paravalvular leaks (PVL) after valve replacement are common and often require intervention. This case study demonstrates successful closure of a very large mitral PVL using two large devices in a high-risk patient.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Medical Device Technology
Background:
- Paravalvular leaks (PVL) are a known complication following valve replacement surgery.
- Significant PVLs can lead to severe complications such as heart failure and hemolysis, necessitating intervention.
- Surgical repair of PVLs carries high risks, making alternative treatments desirable.
Observation:
- The patient presented with a very large mitral paravalvular leak.
- The patient was deemed high-risk for conventional surgical re-intervention.
- Existing devices are not specifically designed for large PVL closure, posing a challenge.
Findings:
- A novel approach utilizing two large closure devices was employed for the mitral PVL.
- The combined device strategy successfully achieved closure of the very large PVL.
- This interventional technique offered a viable alternative to high-risk surgery.
Implications:
- This case suggests that dual large device closure can be effective for very large mitral PVLs in high-risk patients.
- It expands the interventional options for managing complex paravalvular leaks.
- Further research into device-specific adaptations for large PVL closure is warranted.
Related Concept Videos
Mitral Stenosis III: Medical Management
535
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Mitral Regurgitation III: Medical Management
686
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
Aortic Regurgitation III: Medical Management
598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598

